Clinical Scenarios: Treating Patients with Gastric Cancer

This publication highlights a scientific interchange held to evaluate recent data on therapeutic options for advanced gastric and gastroesophageal cancers, explore evidence-based therapy approaches and sequencing strategies in patients with HER2+ disease, and discuss methods to optimize treatment selection and management.

Lakshmi Rajdev, MD, MS, discusses detecting HER2 positivity in patients with gastrointestinal cancers.

Warren S. Brenner, MD, discusses the utilization of fam-trastuzumab deruxtecan-nxki (Enhertu) as a HER2-directed therapy in gastric cancer.

Manish A Shah, MD, discusses the importance of genetic testing in gastrointestinal cancer.